F R Bühler|F W Amann - JoVE Visualize

Showing results (1-10 of 321) with videos related to

Pageof 33

Sort By:

International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1984

Efficacy and tolerance of the new long-acting vasodilator RO 12-4713 in hypertensive patients not managed on beta blockers and diureticsF W Amann, P Bolli, F R Bühler

Hypertension (Dallas, Tex. : 1979)|May 1, 1981

Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertensionF W Amann, P Bolli, W Kiowski, et al.

Schweizerische Medizinische Wochenschrift|December 13, 1980

[Enhanced alpha adrenoreceptor-mediated vasoconstrictor component in essential hypertension]F W Amann, P Bolli, W Kiowski, et al.

Clinical Science (London, England : 1979)|May 1, 1981

Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjectsP van Brummelen, F R Bühler, W Kiowski, et al.

Journal of Cardiovascular Pharmacology|January 1, 1985

Increased beta-adrenoceptor binding capacity is associated with blunted beta-adrenoceptor-mediated cardiovascular responses in essential hypertensionR Landmann, P van Brummelen, F W Amann, et al.

European Journal of Clinical Pharmacology|January 1, 1982

Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertensionP van Brummelen, F R Bühler, F W Amann, et al.

Clinical Science (London, England : 1979)|May 1, 1981

Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive manW Kiowski, F R Bühler, P van Brummelen, et al.

Journal of Cardiovascular Pharmacology|May 1, 1983

Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to ageU L Hulthén, P van Brummelen, F W Amann, et al.

General Pharmacology|January 1, 1983

Verapamil-induced vasodilator response is enhanced in essential hypertensionP Bolli, L Hulthén, F W Amann, et al.

Clinical Pharmacology and Therapeutics|June 1, 1982

Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilationW Kiowski, P van Brummelen, L Hulthén, et al.

Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:

Pageof 33

International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1984

Efficacy and tolerance of the new long-acting vasodilator RO 12-4713 in hypertensive patients not managed on beta blockers and diureticsF W Amann, P Bolli, F R Bühler

Hypertension (Dallas, Tex. : 1979)|May 1, 1981

Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertensionF W Amann, P Bolli, W Kiowski, et al.

Schweizerische Medizinische Wochenschrift|December 13, 1980

[Enhanced alpha adrenoreceptor-mediated vasoconstrictor component in essential hypertension]F W Amann, P Bolli, W Kiowski, et al.

Clinical Science (London, England : 1979)|May 1, 1981

Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjectsP van Brummelen, F R Bühler, W Kiowski, et al.

Journal of Cardiovascular Pharmacology|January 1, 1985

Increased beta-adrenoceptor binding capacity is associated with blunted beta-adrenoceptor-mediated cardiovascular responses in essential hypertensionR Landmann, P van Brummelen, F W Amann, et al.

European Journal of Clinical Pharmacology|January 1, 1982

Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertensionP van Brummelen, F R Bühler, F W Amann, et al.

Clinical Science (London, England : 1979)|May 1, 1981

Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive manW Kiowski, F R Bühler, P van Brummelen, et al.

Journal of Cardiovascular Pharmacology|May 1, 1983

Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to ageU L Hulthén, P van Brummelen, F W Amann, et al.

General Pharmacology|January 1, 1983

Verapamil-induced vasodilator response is enhanced in essential hypertensionP Bolli, L Hulthén, F W Amann, et al.

Clinical Pharmacology and Therapeutics|June 1, 1982

Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilationW Kiowski, P van Brummelen, L Hulthén, et al.

Pageof 33